Savara's valuation will be heavily impacted by the results of its upcoming IMPALA-2 trial for its drug Molgramostim. Learn ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

Targeting a special protein called PD-1 allows cancer treatments such as Keytruda and Opdivo to boost the immune system’s ...

Alliance A091902: A multicenter randomized phase II trial of paclitaxel (P) with or without nivolumab (N) in patients (pts) with advanced angiosarcoma (AS). Reshaping the tumor microenvironment of ...

Trading to commence effective on the market open June 14, 2024WINTER SPRINGS, Fla., June 07, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative ...

Biological sample selection and collection The study objects of pharmacometabolomics can be divided into animal samples (urine, serum, plasma, tissues, organs, saliva, alveolar flush, cerebrospinal ...

Periodontal disease, represented by periodontitis, is the leading cause of tooth loss and affects close to one in five adults ...

Ryan attended The Loomis Chaffee School and graduated from Babson College in 1998. The Family suggests contributions be made to The Alliance Against Alveolar Soft Part Sarcoma (TAAASPS).

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced ...